AI assistant
Sending…
ABVC BIOPHARMA, INC. — Director's Dealing 2021
Nov 15, 2021
34380_dirs_2021-11-15_3c922d1a-da20-4020-9661-edd95d0fc3b6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: ABVC BIOPHARMA, INC. (ABVC)
CIK: 0001173313
Period of Report: 2021-11-08
Reporting Person: Tseng Shih-Chen (Director)
More from ABVC BIOPHARMA, INC.
Interim / Quarterly Report
2026
May 18
Regulatory Filings
2026
Mar 27
Report Publication Announcement
2026
Mar 3
Annual Report
2026
Mar 3
Interim / Quarterly Report
2026
Mar 3
Regulatory Filings
2026
Mar 3
Regulatory Filings
2026
Feb 24
Regulatory Filings
2026
Jan 16
Regulatory Filings
2025
Dec 2
Regulatory Filings
2025
Nov 26